5:56 PM
 | 
May 15, 2013
 |  BC Extra  |  Financial News

Kite raises $20 million in series A

Cancer immunotherapy company Kite Pharma Inc. (Los Angeles, Calif.) raised $20 million in a series A round. The company also converted $15 million in outstanding promissory notes from Kite's seed round into series A stock. New investor Alta...

Read the full 171 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >